Clinical Trials Directory

Trials / Completed

CompletedNCT01079858

Evaluation of FID 114657 in Dry Eye Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to assess the overall Meibomian Gland Dysfunction Subject's preference for a particular product. Dry eye symptom relief will also be evaluated based on clinical evaluation and a set of subject questionnaires.

Conditions

Interventions

TypeNameDescription
OTHERFID 114657 (ORB Preserved Ocular Emulsion)Patients will dose as needed throughout the day (PRN) for 4 weeks.

Timeline

Start date
2010-02-01
Primary completion
2010-04-01
First posted
2010-03-03
Last updated
2012-02-02

Source: ClinicalTrials.gov record NCT01079858. Inclusion in this directory is not an endorsement.